-
Something wrong with this record ?
Serological survey of mumps antibodies in adults in the Czech Republic and the need for changes to the vaccination strategy
J. Smetana, R. Chlibek, I. Hanovcova, R. Sosovickova, L. Smetanova, P. Polcarova, P. Gal, P. Dite,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Free Medical Journals
from 2012 to 1 year ago
PubMed Central
from 2012 to 1 year ago
Europe PubMed Central
from 2012 to 1 year ago
- MeSH
- Adult MeSH
- Disease Outbreaks prevention & control MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Immunization Programs methods MeSH
- Mumps blood immunology prevention & control MeSH
- Antibodies, Viral blood immunology MeSH
- Surveys and Questionnaires MeSH
- Aged MeSH
- Seroepidemiologic Studies MeSH
- Measles immunology prevention & control MeSH
- Measles-Mumps-Rubella Vaccine immunology MeSH
- Vaccination methods MeSH
- Mumps virus immunology MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Czech Republic MeSH
Mumps outbreaks, especially in adolescents and young adults, have been reported in the Czech Republic. The aim of the presented study was to determine the seroprevalence of specific IgG antibodies against mumps in the adult population of the Czech Republic. The study was designed as a multicenter serological survey of adults aged 18 years and over. Specific IgG antibodies against mumps were detected in blood samples using an enzyme-linked immunosorbent assay (ELISA). A total of 1,911 serum samples were examined. The overall seropositivity reached 55.3%. In individual age groups, the highest seropositivity 63% (63.5-65.2%) was recorded in adults aged 40 years and over; the lowest seropositivity was found in adults aged 18-29 years (27.4%). The difference in seropositivity rate between the 18-29 years age group and the 40 years and over age groups was statistically significant (p < 0.001). Only the 18-29 years age group included both vaccinated and unvaccinated (born in the pre-vaccine era) individuals. In vaccinated individuals, seropositivity was reported in only 19.1% of persons; in unvaccinated individuals, seropositivity reached 48.2%. Our results demonstrate the long-term persistence of antibodies following natural infection and the decrease in seropositivity that occurs after vaccination over time. This immunity waning may account for the higher susceptibility of adolescents and young adults to mumps. Therefore, the current vaccination program in the Czech Republic could be considered as less effective. It will be modified with the shifting of the second dose of vaccine from two years of age to the preschool age.
b Department of Rehabilitation University Hospital Hradec Kralove Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19012991
- 003
- CZ-PrNML
- 005
- 20190409152228.0
- 007
- ta
- 008
- 190405s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/21645515.2017.1412021 $2 doi
- 035 __
- $a (PubMed)29206078
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Smetana, Jan $u a Department of Epidemiology , Faculty of Military Health Sciences, University of Defence , Hradec Kralove , Czech Republic.
- 245 10
- $a Serological survey of mumps antibodies in adults in the Czech Republic and the need for changes to the vaccination strategy / $c J. Smetana, R. Chlibek, I. Hanovcova, R. Sosovickova, L. Smetanova, P. Polcarova, P. Gal, P. Dite,
- 520 9_
- $a Mumps outbreaks, especially in adolescents and young adults, have been reported in the Czech Republic. The aim of the presented study was to determine the seroprevalence of specific IgG antibodies against mumps in the adult population of the Czech Republic. The study was designed as a multicenter serological survey of adults aged 18 years and over. Specific IgG antibodies against mumps were detected in blood samples using an enzyme-linked immunosorbent assay (ELISA). A total of 1,911 serum samples were examined. The overall seropositivity reached 55.3%. In individual age groups, the highest seropositivity 63% (63.5-65.2%) was recorded in adults aged 40 years and over; the lowest seropositivity was found in adults aged 18-29 years (27.4%). The difference in seropositivity rate between the 18-29 years age group and the 40 years and over age groups was statistically significant (p < 0.001). Only the 18-29 years age group included both vaccinated and unvaccinated (born in the pre-vaccine era) individuals. In vaccinated individuals, seropositivity was reported in only 19.1% of persons; in unvaccinated individuals, seropositivity reached 48.2%. Our results demonstrate the long-term persistence of antibodies following natural infection and the decrease in seropositivity that occurs after vaccination over time. This immunity waning may account for the higher susceptibility of adolescents and young adults to mumps. Therefore, the current vaccination program in the Czech Republic could be considered as less effective. It will be modified with the shifting of the second dose of vaccine from two years of age to the preschool age.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a protilátky virové $x krev $x imunologie $7 D000914
- 650 _2
- $a epidemický výskyt choroby $x prevence a kontrola $7 D004196
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a očkovací programy $x metody $7 D017589
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a spalničky $x imunologie $x prevence a kontrola $7 D008457
- 650 _2
- $a vakcína proti spalničkám, příušnicím a zarděnkám $x imunologie $7 D022542
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a příušnice $x krev $x imunologie $x prevence a kontrola $7 D009107
- 650 _2
- $a virus příušnic $x imunologie $7 D009109
- 650 _2
- $a séroepidemiologické studie $7 D016036
- 650 _2
- $a průzkumy a dotazníky $7 D011795
- 650 _2
- $a vakcinace $x metody $7 D014611
- 650 _2
- $a mladý dospělý $7 D055815
- 651 _2
- $a Česká republika $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Chlibek, Roman $u a Department of Epidemiology , Faculty of Military Health Sciences, University of Defence , Hradec Kralove , Czech Republic.
- 700 1_
- $a Hanovcova, Irena $u a Department of Epidemiology , Faculty of Military Health Sciences, University of Defence , Hradec Kralove , Czech Republic.
- 700 1_
- $a Sosovickova, Renata $u a Department of Epidemiology , Faculty of Military Health Sciences, University of Defence , Hradec Kralove , Czech Republic.
- 700 1_
- $a Smetanova, Libuse $u b Department of Rehabilitation , University Hospital , Hradec Kralove , Czech Republic.
- 700 1_
- $a Polcarova, Petra $u a Department of Epidemiology , Faculty of Military Health Sciences, University of Defence , Hradec Kralove , Czech Republic.
- 700 1_
- $a Gal, Peter $u c Military Health Institute , Ceske Budejovice , Czech Republic.
- 700 1_
- $a Dite, Petr $u a Department of Epidemiology , Faculty of Military Health Sciences, University of Defence , Hradec Kralove , Czech Republic. d Military Health Institute , Brno , Czech Republic.
- 773 0_
- $w MED00181409 $t Human vaccines & immunotherapeutics $x 2164-554X $g Roč. 14, č. 4 (2018), s. 887-893
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29206078 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20190409152242 $b ABA008
- 999 __
- $a ok $b bmc $g 1392301 $s 1051296
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 14 $c 4 $d 887-893 $e 20180116 $i 2164-554X $m Human vaccines & immunotherapeutics $n Hum Vaccin Immunother $x MED00181409
- LZP __
- $a Pubmed-20190405
